Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.
Impact
If enacted, S1213 would directly impact the economics of pharmacy operations, specifically outlining how fees can be assessed for prescription processing. This legislation is expected to streamline prescription practices in New Jersey, fostering a more modern healthcare environment where electronic prescriptions are treated equitably to traditional ones. Proponents believe this could lead to increased efficiency in the healthcare system, reducing potential delays caused by additional processing fees that might discourage electronic prescriptions.
Summary
Senate Bill 1213 aims to amend existing legislation related to electronic prescriptions by prohibiting pharmacies from charging additional fees for processing prescriptions transmitted by telephone or electronically, unless those same fees apply to written prescriptions. The bill's sponsor, Senator James Beach, argues that this measure will encourage the use of electronic prescriptions, which are deemed more efficient compared to their written counterparts. By ensuring that pharmacies do not impose extra costs on electronically-transmitted prescriptions, the bill seeks to promote broader adoption of this technology in enhancing patient care.
Contention
While the bill seeks to modernize prescription processing, there may be contention regarding its implications for pharmacies' revenue models. Some critics could argue that limiting fee structures may negatively impact small pharmacies that rely on these fees to sustain their operations. Additionally, concerns may arise surrounding the security and verification of electronically transmitted prescriptions, especially for controlled substances. Thus, the balance between encouraging technological advancements in healthcare and maintaining fair business practices for pharmacies is likely to be a key point of debate.
Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.